
Global Spatial Omics Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Spatial Omics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Spatial Omics market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Spatial Omics market include Akoya Biosciences, Biognosys AG, BioSpyder Technologies, Bio-Techne, Brooks Automation, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics and Dovetail Genomics, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Spatial Omics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Spatial Omics, also provides the value of main regions and countries. Of the upcoming market potential for Spatial Omics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Spatial Omics revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Spatial Omics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Spatial Omics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Spatial Omics Segment by Company
Akoya Biosciences
Biognosys AG
BioSpyder Technologies
Bio-Techne
Brooks Automation
Bruker Corporation
Danaher Corporation
Diagenode Diagnostics
Dovetail Genomics
IonPath
Nanostring Technologies
PerkinElmer
Rebus Biosystems
S2 Genomics
Seven Bridges Genomics
Vizgen Corporation
Spatial Omics Segment by Type
Spatial Transcriptomic
Spatial Genomics
Spatial Proteomics
Spatial Omics Segment by Application
Laboratory
Research Institutions
Other
Spatial Omics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Spatial Omics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Spatial Omics key companies, revenue, market share, and recent developments.
3. To split the Spatial Omics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Spatial Omics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Spatial Omics significant trends, drivers, influence factors in global and regions.
6. To analyze Spatial Omics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spatial Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Omics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spatial Omics industry.
Chapter 3: Detailed analysis of Spatial Omics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Spatial Omics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Spatial Omics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
According to APO Research, the global Spatial Omics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Spatial Omics market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Spatial Omics market include Akoya Biosciences, Biognosys AG, BioSpyder Technologies, Bio-Techne, Brooks Automation, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics and Dovetail Genomics, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Spatial Omics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Spatial Omics, also provides the value of main regions and countries. Of the upcoming market potential for Spatial Omics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Spatial Omics revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Spatial Omics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Spatial Omics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Spatial Omics Segment by Company
Akoya Biosciences
Biognosys AG
BioSpyder Technologies
Bio-Techne
Brooks Automation
Bruker Corporation
Danaher Corporation
Diagenode Diagnostics
Dovetail Genomics
IonPath
Nanostring Technologies
PerkinElmer
Rebus Biosystems
S2 Genomics
Seven Bridges Genomics
Vizgen Corporation
Spatial Omics Segment by Type
Spatial Transcriptomic
Spatial Genomics
Spatial Proteomics
Spatial Omics Segment by Application
Laboratory
Research Institutions
Other
Spatial Omics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Spatial Omics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Spatial Omics key companies, revenue, market share, and recent developments.
3. To split the Spatial Omics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Spatial Omics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Spatial Omics significant trends, drivers, influence factors in global and regions.
6. To analyze Spatial Omics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spatial Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Omics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spatial Omics industry.
Chapter 3: Detailed analysis of Spatial Omics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Spatial Omics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Spatial Omics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Table of Contents
208 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Spatial Omics Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Spatial Omics Market Size (2020-2031)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Spatial Omics Market Dynamics
- 2.1 Spatial Omics Industry Trends
- 2.2 Spatial Omics Industry Drivers
- 2.3 Spatial Omics Industry Opportunities and Challenges
- 2.4 Spatial Omics Industry Restraints
- 3 Spatial Omics Market by Company
- 3.1 Global Spatial Omics Company Revenue Ranking in 2024
- 3.2 Global Spatial Omics Revenue by Company (2020-2025)
- 3.3 Global Spatial Omics Company Ranking (2023-2025)
- 3.4 Global Spatial Omics Company Manufacturing Base and Headquarters
- 3.5 Global Spatial Omics Company Product Type and Application
- 3.6 Global Spatial Omics Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Spatial Omics Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.7.3 2024 Spatial Omics Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
- 4 Spatial Omics Market by Type
- 4.1 Spatial Omics Type Introduction
- 4.1.1 Spatial Transcriptomic
- 4.1.2 Spatial Genomics
- 4.1.3 Spatial Proteomics
- 4.2 Global Spatial Omics Sales Value by Type
- 4.2.1 Global Spatial Omics Sales Value by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Spatial Omics Sales Value by Type (2020-2031)
- 4.2.3 Global Spatial Omics Sales Value Share by Type (2020-2031)
- 5 Spatial Omics Market by Application
- 5.1 Spatial Omics Application Introduction
- 5.1.1 Laboratory
- 5.1.2 Research Institutions
- 5.1.3 Other
- 5.2 Global Spatial Omics Sales Value by Application
- 5.2.1 Global Spatial Omics Sales Value by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Spatial Omics Sales Value by Application (2020-2031)
- 5.2.3 Global Spatial Omics Sales Value Share by Application (2020-2031)
- 6 Spatial Omics Regional Value Analysis
- 6.1 Global Spatial Omics Sales Value by Region: 2020 VS 2024 VS 2031
- 6.2 Global Spatial Omics Sales Value by Region (2020-2031)
- 6.2.1 Global Spatial Omics Sales Value by Region: 2020-2025
- 6.2.2 Global Spatial Omics Sales Value by Region (2026-2031)
- 6.3 North America
- 6.3.1 North America Spatial Omics Sales Value (2020-2031)
- 6.3.2 North America Spatial Omics Sales Value Share by Country, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Spatial Omics Sales Value (2020-2031)
- 6.4.2 Europe Spatial Omics Sales Value Share by Country, 2024 VS 2031
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Spatial Omics Sales Value (2020-2031)
- 6.5.2 Asia-Pacific Spatial Omics Sales Value Share by Country, 2024 VS 2031
- 6.6 South America
- 6.6.1 South America Spatial Omics Sales Value (2020-2031)
- 6.6.2 South America Spatial Omics Sales Value Share by Country, 2024 VS 2031
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Spatial Omics Sales Value (2020-2031)
- 6.7.2 Middle East & Africa Spatial Omics Sales Value Share by Country, 2024 VS 2031
- 7 Spatial Omics Country-level Value Analysis
- 7.1 Global Spatial Omics Sales Value by Country: 2020 VS 2024 VS 2031
- 7.2 Global Spatial Omics Sales Value by Country (2020-2031)
- 7.2.1 Global Spatial Omics Sales Value by Country (2020-2025)
- 7.2.2 Global Spatial Omics Sales Value by Country (2026-2031)
- 7.3 USA
- 7.3.1 USA Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.3.2 USA Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.3.3 USA Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.4 Canada
- 7.4.1 Canada Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.4.2 Canada Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.4.3 Canada Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.5 Mexico
- 7.5.1 Mexico Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.5.2 Mexico Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.5.3 Mexico Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.6 Germany
- 7.6.1 Germany Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.6.2 Germany Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Germany Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.7 France
- 7.7.1 France Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.7.2 France Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.7.3 France Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.8 U.K.
- 7.8.1 U.K. Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.8.2 U.K. Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.8.3 U.K. Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.9 Italy
- 7.9.1 Italy Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.9.2 Italy Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.9.3 Italy Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.10 Spain
- 7.10.1 Spain Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.10.2 Spain Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.10.3 Spain Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.11 Russia
- 7.11.1 Russia Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.11.2 Russia Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Russia Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.12 Netherlands
- 7.12.1 Netherlands Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.12.2 Netherlands Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Netherlands Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.13.2 Nordic Countries Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Nordic Countries Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.14 China
- 7.14.1 China Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.14.2 China Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.14.3 China Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.15 Japan
- 7.15.1 Japan Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.15.2 Japan Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Japan Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.16 South Korea
- 7.16.1 South Korea Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.16.2 South Korea Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.16.3 South Korea Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.17 India
- 7.17.1 India Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.17.2 India Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.17.3 India Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.18 Australia
- 7.18.1 Australia Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.18.2 Australia Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.18.3 Australia Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.19.2 Southeast Asia Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.19.3 Southeast Asia Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.20 Brazil
- 7.20.1 Brazil Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.20.2 Brazil Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Brazil Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.21 Argentina
- 7.21.1 Argentina Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.21.2 Argentina Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Argentina Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.22 Chile
- 7.22.1 Chile Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.22.2 Chile Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Chile Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.23 Colombia
- 7.23.1 Colombia Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.23.2 Colombia Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Colombia Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.24 Peru
- 7.24.1 Peru Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.24.2 Peru Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Peru Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.25.2 Saudi Arabia Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Saudi Arabia Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.26 Israel
- 7.26.1 Israel Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.26.2 Israel Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Israel Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.27 UAE
- 7.27.1 UAE Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.27.2 UAE Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.27.3 UAE Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.28 Turkey
- 7.28.1 Turkey Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.28.2 Turkey Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Turkey Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.29 Iran
- 7.29.1 Iran Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.29.2 Iran Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.29.3 Iran Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 7.30 Egypt
- 7.30.1 Egypt Spatial Omics Sales Value Growth Rate (2020-2031)
- 7.30.2 Egypt Spatial Omics Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Egypt Spatial Omics Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Akoya Biosciences
- 8.1.1 Akoya Biosciences Comapny Information
- 8.1.2 Akoya Biosciences Business Overview
- 8.1.3 Akoya Biosciences Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.1.4 Akoya Biosciences Spatial Omics Product Portfolio
- 8.1.5 Akoya Biosciences Recent Developments
- 8.2 Biognosys AG
- 8.2.1 Biognosys AG Comapny Information
- 8.2.2 Biognosys AG Business Overview
- 8.2.3 Biognosys AG Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.2.4 Biognosys AG Spatial Omics Product Portfolio
- 8.2.5 Biognosys AG Recent Developments
- 8.3 BioSpyder Technologies
- 8.3.1 BioSpyder Technologies Comapny Information
- 8.3.2 BioSpyder Technologies Business Overview
- 8.3.3 BioSpyder Technologies Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.3.4 BioSpyder Technologies Spatial Omics Product Portfolio
- 8.3.5 BioSpyder Technologies Recent Developments
- 8.4 Bio-Techne
- 8.4.1 Bio-Techne Comapny Information
- 8.4.2 Bio-Techne Business Overview
- 8.4.3 Bio-Techne Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.4.4 Bio-Techne Spatial Omics Product Portfolio
- 8.4.5 Bio-Techne Recent Developments
- 8.5 Brooks Automation
- 8.5.1 Brooks Automation Comapny Information
- 8.5.2 Brooks Automation Business Overview
- 8.5.3 Brooks Automation Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.5.4 Brooks Automation Spatial Omics Product Portfolio
- 8.5.5 Brooks Automation Recent Developments
- 8.6 Bruker Corporation
- 8.6.1 Bruker Corporation Comapny Information
- 8.6.2 Bruker Corporation Business Overview
- 8.6.3 Bruker Corporation Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.6.4 Bruker Corporation Spatial Omics Product Portfolio
- 8.6.5 Bruker Corporation Recent Developments
- 8.7 Danaher Corporation
- 8.7.1 Danaher Corporation Comapny Information
- 8.7.2 Danaher Corporation Business Overview
- 8.7.3 Danaher Corporation Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.7.4 Danaher Corporation Spatial Omics Product Portfolio
- 8.7.5 Danaher Corporation Recent Developments
- 8.8 Diagenode Diagnostics
- 8.8.1 Diagenode Diagnostics Comapny Information
- 8.8.2 Diagenode Diagnostics Business Overview
- 8.8.3 Diagenode Diagnostics Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.8.4 Diagenode Diagnostics Spatial Omics Product Portfolio
- 8.8.5 Diagenode Diagnostics Recent Developments
- 8.9 Dovetail Genomics
- 8.9.1 Dovetail Genomics Comapny Information
- 8.9.2 Dovetail Genomics Business Overview
- 8.9.3 Dovetail Genomics Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.9.4 Dovetail Genomics Spatial Omics Product Portfolio
- 8.9.5 Dovetail Genomics Recent Developments
- 8.10 IonPath
- 8.10.1 IonPath Comapny Information
- 8.10.2 IonPath Business Overview
- 8.10.3 IonPath Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.10.4 IonPath Spatial Omics Product Portfolio
- 8.10.5 IonPath Recent Developments
- 8.11 Nanostring Technologies
- 8.11.1 Nanostring Technologies Comapny Information
- 8.11.2 Nanostring Technologies Business Overview
- 8.11.3 Nanostring Technologies Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.11.4 Nanostring Technologies Spatial Omics Product Portfolio
- 8.11.5 Nanostring Technologies Recent Developments
- 8.12 PerkinElmer
- 8.12.1 PerkinElmer Comapny Information
- 8.12.2 PerkinElmer Business Overview
- 8.12.3 PerkinElmer Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.12.4 PerkinElmer Spatial Omics Product Portfolio
- 8.12.5 PerkinElmer Recent Developments
- 8.13 Rebus Biosystems
- 8.13.1 Rebus Biosystems Comapny Information
- 8.13.2 Rebus Biosystems Business Overview
- 8.13.3 Rebus Biosystems Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.13.4 Rebus Biosystems Spatial Omics Product Portfolio
- 8.13.5 Rebus Biosystems Recent Developments
- 8.14 S2 Genomics
- 8.14.1 S2 Genomics Comapny Information
- 8.14.2 S2 Genomics Business Overview
- 8.14.3 S2 Genomics Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.14.4 S2 Genomics Spatial Omics Product Portfolio
- 8.14.5 S2 Genomics Recent Developments
- 8.15 Seven Bridges Genomics
- 8.15.1 Seven Bridges Genomics Comapny Information
- 8.15.2 Seven Bridges Genomics Business Overview
- 8.15.3 Seven Bridges Genomics Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.15.4 Seven Bridges Genomics Spatial Omics Product Portfolio
- 8.15.5 Seven Bridges Genomics Recent Developments
- 8.16 Vizgen Corporation
- 8.16.1 Vizgen Corporation Comapny Information
- 8.16.2 Vizgen Corporation Business Overview
- 8.16.3 Vizgen Corporation Spatial Omics Revenue and Gross Margin (2020-2025)
- 8.16.4 Vizgen Corporation Spatial Omics Product Portfolio
- 8.16.5 Vizgen Corporation Recent Developments
- 9 Concluding Insights
- 10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.